View on Pubmed.gov 21562580 | View on doi.org 10.1038/nrc3066
Cell-free nucleic acids as biomarkers in cancer patients.
- Institute of Tumour Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany.
Abstract
DNA, mRNA and microRNA are released and circulate in the blood of cancer patients. Changes in the levels of circulating nucleic acids have been associated with tumour burden and malignant progression. In the past decade a wealth of information indicating the potential use of circulating nucleic acids for cancer screening, prognosis and monitoring of the efficacy of anticancer therapies has emerged. In this Review, we discuss these findings with a specific focus on the clinical utility of cell-free nucleic acids as blood biomarkers.
References
Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):67-71
Trends Mol Med. 2010 Sep;16(9):398-406
Br J Cancer. 2009 Nov 17;101(10):1724-30
Liver Int. 2008 Mar;28(3):393-401
Cited by 2690 citations (total)
Journal Article
Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer.
Electronic publication date February 14, 2014
Yi Kang [...] Jia Shang et al.
BACKGROUND
Our aims were to detect circulating cell-free human telomerase reverse transcriptase (hTERT) mRNA in the plasma of gastric cancer patients...
Comparative Study Journal Article Research Support, U.S. Gov't, Non-P.H.S.
Comparing the MicroRNA spectrum between serum and plasma.
Electronic publication date April 12, 2013
Kai Wang [...] David J Galas et al.
MicroRNAs (miRNAs) are small, non-coding RNAs that regulate various biological processes, primarily through interaction with messenger RNAs. The levels of...
Conflict of interest statement
MeSH
- •
- •
- •
- •
Specialties
- •
- •
- •
Substances
- •
- •
- •
- •